Havana, Cuba

Amaury Pupo Meriño


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Biotechnology: Amaury Pupo Meriño

Introduction: Amaury Pupo Meriño is a distinguished inventor based in Havana, Cuba, recognized for his contributions to the field of biotechnology. With a focus on innovative solutions that address significant health challenges, his work exemplifies the intersection of science and practical application.

Latest Patents: Amaury holds a notable patent titled "TGF-β-derived polypeptides and uses thereof." This invention pertains to mutated polypeptides of the TGF-β molecule, which exhibit a significant homology with the human TGF-β sequence. The unique characteristics of these muteins allow them to evade interaction with ALK5 while retaining their engagement with other receptors such as TβRII and TβRIII. This innovation is particularly valuable as it antagonizes the signaling of various TGF-β ligands, showcasing significant immunomodulatory effects. The patent outlines potential applications in pharmaceutical compositions aimed at modulating the immune system for treating conditions like cancer, fibrosis-related diseases, and chronic infections.

Career Highlights: Amaury Pupo Meriño is affiliated with the Centro de Inmunología Molecular, a leading research institution committed to advancing knowledge and therapies in immunology and biotechnology. His role in this prestigious organization reflects his dedication to innovative research and development in the medical field.

Collaborations: Throughout his career, Amaury has collaborated with esteemed colleagues, including Ángel De Jesús Corria Osorio and Kalet León Monzón. These partnerships highlight the collective effort within the research community to push the boundaries of biotechnology and improve therapeutic outcomes for patients.

Conclusion: Amaury Pupo Meriño stands as a prominent figure in the biotechnology sector. His innovative approach to developing TGF-β-derived polypeptides showcases how targeted research can lead to potential breakthroughs in disease treatment. Through his patent and collaborative efforts, he continues to contribute valuable insights to the science of immunology, underscoring the significance of innovation in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…